QuidelOrtho Corporation
QDEL
Positions held
Your positionsQDEL isn't in your positions.
Add it to see shares, cost, and P&L here.
Bull / bear case
Site-generated summary from fundamentals, news, and score — not investment advice. As of 2026-10-08.
- QuidelOrtho Corporation operates in the medical devices industry, which is experiencing growth due to increasing demand for diagnostic testing and healthcare solutions.
- Revenue increased by 2% compared to the prior quarter, reaching $631 million.
- Gross margin improved to 43.3%, up from 42.6% in the previous quarter.
- The company has a high debt-to-equity ratio of 173.3, indicating potential financial risk.
- Net income for the latest quarter was -$92.9 million, reflecting ongoing profitability challenges.
- Operating margin remains negative at -2.4%, highlighting operational inefficiencies.
Fundamentals
| Market cap | $851.02M | Enterprise value | $3.80B | Trailing P/E | — | Forward P/E | 8.61 |
| PEG | 2.06 | Price / book | 0.48 | Beta | 0.78 | Dividend yield | 0.00% |
| Revenue growth | 2.8% | Earnings growth | — | Gross margin | 44.9% | Operating margin | -2.1% |
| Profit margin | -39.2% | ROE | -45.9% | ROA | 0.4% | Debt / equity | 1.73 |
| Current ratio | 1.39 | Free cash flow | $146.76M | Analyst recommendation | hold | Mean target | $14.67 |
| 52w high | $35.58 | 52w low | $9.92 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $631M | $620M | $724M | $700M | $614M | — |
| Op margin | -2.4% | -4.4% | -5.2% | 6.5% | -0.3% | — |
| Net income | -$92.9M | -$91.8M | -$131M | -$733M | -$255M | — |
| Gross margin | 43.3% | 42.6% | 44.3% | 47.9% | 44.8% | — |
| Gross profit | $273M | $264M | $320M | $336M | $275M | — |
| Operating income | -$15.3M | -$27.4M | -$37.3M | $45.2M | -$1.8M | — |
- Revenue +2% vs prior quarter ($631M vs $620M).
- Gross margin 43.3% (was 42.6% prior quarter).
- Operating margin expanded to -2.4%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $2.7B | $2.8B | $3.0B | $3.3B | — |
| Op margin | 2.0% | 1.6% | 8.6% | 30.1% | — |
| Net income | -$1.1B | -$2.1B | -$10.1M | $549M | — |
| Gross margin | 46.7% | 46.2% | 49.9% | 59.3% | — |
| Gross profit | $1.3B | $1.3B | $1.5B | $1.9B | — |
| Operating income | $54.8M | $45.8M | $257M | $983M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-07 · QuidelOrtho Appoints Sanjeev Sharma as Vice President of Investor Relations
2026-09-25 · 2 Healthcare Stocks with Impressive Fundamentals and 1 Facing Challenges
2026-09-24 · Early Intervention Aids Emergency Medicine Teams in Identifying and Personalizing Sepsis Treatment
2026-09-02 · 3 Stocks Under $50 We Think Twice About
2026-08-27 · Faster Answers, Better Decisions: ADLM 2026 Highlights
2026-08-26 · 1 Russell 2000 Stock Worth Your Attention and 2 That Underwhelm
2026-08-24 · Here's What Is Shaping Abbott's Diagnostics Growth
2026-08-18 · QuidelOrtho (QDEL) Is Up 6.0% After Cutting 2026 Revenue Outlook Amid Narrowing Losses – What's Changed
2026-08-17 · QDEL's 2026 Outlook Cut Deepens China and Respiratory Risk Concerns
2026-08-17 · Is QDEL Worth Buying as China Risks Clash With Resilient Core Growth?
Price (daily)
Full chart · RSI · MACD · patterns